Eukaryotic (translation) initiation factor 4A (eIF4A) inhibition may be used to treat Huntington’s disease by decreasing the expression of huntingtin

Publication date: May 2018
Source:Medical Hypotheses, Volume 114
Author(s): Thomas E. Webb




http://ift.tt/2pmZpvV